Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 2002 Aug;48:1301–1304.

Update on motherisk updates. Seven years of questions and answers.

Adrienne Einarson 1, Galina Portnoi 1, Gideon Koren 1
PMCID: PMC2214092  PMID: 12228958

Abstract

QUESTION: Every month I read the Motherisk Updates in your journal and find them very helpful in counseling my patients on exposures during pregnancy and breastfeeding. I was wondering: what are the most common questions you receive from family physicians? ANSWER: Since the Motherisk Update began, we have received an increasing number of inquiries from family physicians across Canada. Most questions are about drug exposures. The three classes of drugs asked about most often are antidepressants, antiepileptics, and antihistamines.

Full Text

The Full Text of this article is available as a PDF (116.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burch K. J., Wells B. G. Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics. 1992 Apr;89(4 Pt 1):676–677. [PubMed] [Google Scholar]
  2. Chambers C. D., Johnson K. A., Dick L. M., Felix R. J., Jones K. L. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996 Oct 3;335(14):1010–1015. doi: 10.1056/NEJM199610033351402. [DOI] [PubMed] [Google Scholar]
  3. Duffull S. B., Begg E. J., Ilett K. F. Fluoxetine distribution in human milk. J Clin Pharmacol. 1996 Nov;36(11):1078–1079. doi: 10.1177/009127009603601112. [DOI] [PubMed] [Google Scholar]
  4. Einarson A., Selby P., Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci. 2001 Jan;26(1):44–48. [PMC free article] [PubMed] [Google Scholar]
  5. Einarson A., Selby P., Koren G. Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation. Can Fam Physician. 2001 Mar;47:489–490. [PMC free article] [PubMed] [Google Scholar]
  6. Ito S. Drug therapy for breast-feeding women. N Engl J Med. 2000 Jul 13;343(2):118–126. doi: 10.1056/NEJM200007133430208. [DOI] [PubMed] [Google Scholar]
  7. Ito S., Lieu M., Chan W., Koren G. Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. Can Fam Physician. 1999 Apr;45:897–899. [PMC free article] [PubMed] [Google Scholar]
  8. Koren G. Chickenpox during pregnancy. Small but real risk. Can Fam Physician. 1995 Sep;41:1477–1478. [PMC free article] [PubMed] [Google Scholar]
  9. Koren G. First-trimester exposure to fluoxetine (prozac). Does it affect pregnancy outcome? Can Fam Physician. 1996 Jan;42:43–44. [PMC free article] [PubMed] [Google Scholar]
  10. Koren G., Moretti M., Ito S. Continuing drug therapy while breastfeeding. Part 2. Common misconceptions of physicians. Can Fam Physician. 1999 May;45:1173–1175. [PMC free article] [PubMed] [Google Scholar]
  11. Nulman I., Rovet J., Stewart D. E., Wolpin J., Gardner H. A., Theis J. G., Kulin N., Koren G. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997 Jan 23;336(4):258–262. doi: 10.1056/NEJM199701233360404. [DOI] [PubMed] [Google Scholar]
  12. Pastuszak A., Schick-Boschetto B., Zuber C., Feldkamp M., Pinelli M., Sihn S., Donnenfeld A., McCormack M., Leen-Mitchell M., Woodland C. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) JAMA. 1993 May 5;269(17):2246–2248. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES